Hestia Insight Inc.

Equities

HSTA

US42815H1095

Diversified Investment Services

Market Closed - OTC Markets Other stock markets 17:20:45 27/06/2024 BST			5-day change	1st Jan Change
0.148 ^USD	-7.50%		+5.71%	-40.80%

04-22	Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
03-14	Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023	CI

Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2021

April 19, 2021 at 08:12 pm

Hestia Insight Inc. announced earnings results for the first quarter ended February 28, 2021. For the first quarter, the company announced total revenue was USD 10,000 compared to USD 30,000 a year ago. Operating loss was USD 42,906 compared to operating Income of USD 36 a year ago. Net income was USD 8.034 million compared to net loss of USD 8,855 a year ago.

Latest news about Hestia Insight Inc.

Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024	04-22	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023	03-14	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	13/10/23	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	14/07/23	CI
Hestia Insight Inc. entered into a Letter of Intent to acquire RecentCare Biomedical, Inc.	17/05/23	CI
Hestia Insight Inc. signed letter of intent to acquire Prisma Biotech Corporation .	09/05/23	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	14/04/23	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2022	24/02/23	CI
Hestia Insight Inc. Auditor Raises 'Going Concern' Doubt	23/02/23	CI
Hestia Insight Inc. Appoints T.Z. Chaung as Advisory Board Member	05/01/23	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	17/10/22	CI
Hestia Insight Inc. Announces Advisory Board to Assist in Company Growth	28/07/22	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	14/07/22	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	13/04/22	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2021	25/02/22	CI
Hestia Insight Inc. Auditor Raises 'Going Concern' Doubt	24/02/22	CI
Hestia Insight Inc. Appoints Eugene Cha as Director of the Company	10/01/22	CI
Hestia Insight Inc. Enters into Memorandum of Understanding to Obtain Exclusive License to Brain Health and Functionality Technologies for the Treatment of Mental Health Conditions	29/12/21	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2021	12/10/21	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2021	06/07/21	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2021	19/04/21	CI
Hestia Insight Opens Two Offices, One in Taipei, the Other in Shanghai	26/05/20	CI
Hestia Insight Inc. will Change its Ticker to HSTA from LUXID	05/06/19	CI

Chart Hestia Insight Inc.

Duration

Period

More charts

Company Profile

Hestia Insight Inc. is focused primarily on the healthcare and biotech sectors through its two wholly owned subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA HEALTH INC., doing business as Hestia Vending (Hestia Vending). Hestia Investments provides strategic consulting, medical supply sales and marketing support, management, and capital markets advisory services for select micro, small and medium sized companies within the healthcare and biotech sectors. Hestia Vending operates within the healthy food, beverage and wellness products industry and the smart vending machine industry. It makes strategic acquisitions of emerging growth companies with sciences and technologies. It also intends to pursue the acquisition and development of healthcare related technologies in the healthcare and biotech sectors through acquisition, licensing or joint ventures. It also provides sales and marketing guidance and services and capital markets advisory services to its clients.

Sector

Diversified Investment Services

More about the company

Income Statement Evolution

More financial data

Sector Diversified Investment Services

	1st Jan change	Capi.
HESTIA INSIGHT INC.	-40.80%	4.14M
MACQUARIE GROUP LIMITED	+11.47%	49.83B
EQUITABLE HOLDINGS, INC.	+22.70%	13.29B
SBI HOLDINGS, INC.	+28.22%	7.64B
VOYA FINANCIAL, INC.	-2.48%	7.16B
FIRST CAPITAL SECURITIES CO., LTD.	-12.39%	2.94B
AJ BELL PLC	+21.25%	1.98B
AMP LIMITED	+17.74%	1.9B
L1 LONG SHORT FUND LIMITED	+7.43%	1.32B
BBGI GLOBAL INFRASTRUCTURE S.A.	-6.21%	1.2B

Diversified Investment Services